In patients with acute ischemic stroke, do different thrombolytic doses, agents, or routes of administration lead to different outcomes?

Ann Emerg Med. 2014 Apr;63(4):435-6. doi: 10.1016/j.annemergmed.2013.10.010. Epub 2013 Nov 5.

Authors

Adaira Landry¹, Mark Foran¹, Alex Koyfman²

Affiliations

¹ Department of Emergency Medicine, New York University School of Medicine, Bellevue Hospital Center, New York, NY.
² Division of Emergency Medicine, University of Illinois College of Medicine at Peoria, OSF Saint Francis Medical Center, Peoria, IL.

PMID: 24199840
DOI: 10.1016/j.annemergmed.2013.10.010

No abstract available

Publication types

Editorial
Comment

MeSH terms

Brain Ischemia / drug therapy*
Cerebral Hemorrhage / chemically induced*
Fibrinolytic Agents / administration & dosage*
Humans
Stroke / drug therapy*
Thrombolytic Therapy*

Substances

Fibrinolytic Agents